Nature·4 min read·hard
Identification of NUDT6 and LINGO1 as candidate genes for nCRT-associated signatures to neoadjuvant chemoradiotherapy in rectal cancer patients
W
Wang, Qian
✦AI Summary
Researchers have identified NUDT6 and LINGO1 as potential genetic biomarkers for predicting patient response to neoadjuvant chemoradiotherapy in rectal cancer. The study utilized bioinformatics and machine learning to analyze gene expression, offering a potential tool for personalized treatment planning.
Why it matters
Identifying specific genetic signatures can improve the efficacy of cancer treatments by allowing clinicians to predict which patients will respond best to specific therapies.
Scientific Reports volume 16 , Article number: 34034 ( 2026 ) Cite this article
sciencehealth
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in